Parsons Capital Management’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-36,291
| Closed | -$227K | – | 422 |
|
|
2022
Q2 | $227K | Buy |
36,291
+15,000
| +70% | +$93.8K | 0.02% | 385 |
|
|
2022
Q1 | $76K | Sell |
21,291
-588
| -3% | -$2.1K | 0.01% | 420 |
|
|
2021
Q4 | $110K | Sell |
21,879
-1,725
| -7% | -$8.67K | 0.01% | 431 |
|
|
2021
Q3 | $173K | Buy |
23,604
+475
| +2% | +$3.48K | 0.01% | 413 |
|
|
2021
Q2 | $199K | Hold |
23,129
| – | – | 0.02% | 412 |
|
|
2021
Q1 | $250K | Hold |
23,129
| – | – | 0.02% | 367 |
|
|
2020
Q4 | $228K | Buy |
23,129
+8,528
| +58% | +$84.1K | 0.02% | 351 |
|
|
2020
Q3 | $78K | Sell |
14,601
-375
| -3% | -$2K | 0.01% | 347 |
|
|
2020
Q2 | $88K | Sell |
14,976
-5,834
| -28% | -$34.3K | 0.01% | 329 |
|
|
2020
Q1 | $77K | Sell |
20,810
-2,375
| -10% | -$8.79K | 0.01% | 306 |
|
|
2019
Q4 | $147K | Sell |
23,185
-45,381
| -66% | -$288K | 0.01% | 338 |
|
|
2019
Q3 | $960K | Sell |
68,566
-750
| -1% | -$10.5K | 0.1% | 183 |
|
|
2019
Q2 | $1.02M | Buy |
69,316
+75
| +0.1% | +$1.11K | 0.11% | 174 |
|
|
2019
Q1 | $2.91M | Sell |
69,241
-100
| -0.1% | -$4.2K | 0.32% | 75 |
|
|
2018
Q4 | $2.88M | Hold |
69,341
| – | – | 0.35% | 69 |
|
|
2018
Q3 | $3.34M | Sell |
69,341
-962
| -1% | -$46.4K | 0.35% | 72 |
|
|
2018
Q2 | $3.33M | Sell |
70,303
-103
| -0.1% | -$4.88K | 0.38% | 66 |
|
|
2018
Q1 | $4.33M | Sell |
70,406
-76
| -0.1% | -$4.68K | 0.5% | 45 |
|
|
2017
Q4 | $3.79M | Buy |
70,482
+50
| +0.1% | +$2.69K | 0.42% | 58 |
|
|
2017
Q3 | $4.74M | Buy |
70,432
+1,500
| +2% | +$101K | 0.56% | 43 |
|
|
2017
Q2 | $3.73M | Buy |
68,932
+10,571
| +18% | +$572K | 0.46% | 51 |
|
|
2017
Q1 | $2.08M | Buy |
58,361
+9,570
| +20% | +$341K | 0.26% | 101 |
|
|
2016
Q4 | $1.56M | Buy |
+48,791
| New | +$1.56M | 0.21% | 122 |
|
|
2016
Q3 | – | Sell |
-27,953
| Closed | -$1.06M | – | 342 |
|
|
2016
Q2 | $1.06M | Buy |
+27,953
| New | +$1.06M | 0.14% | 154 |
|